"Doctors say the explosion of new treatments can also be too much to keep up with: The Food and Drug Administration has approved an average of one new cancer treatment a week for the past five years, an exceptional pace." [from The New York Times reporter Gina Kolata.]
We simply can't keep track of - much less assess - the possibilities generated by new R&D in so many fields. Even experts need tools to capture, synthesize and decide to act on new products and standards of care.
No comments:
Post a Comment